Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04025528
Other study ID # 258045
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 20, 2019
Est. completion date July 2024

Study information

Verified date March 2023
Source Guy's and St Thomas' NHS Foundation Trust
Contact Michael Cheng, MBBS
Phone +44 02071888070
Email michael.cheng@gstt.nhs.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Breathing is impacted by obesity. Early changes are characterised by significant breathing abnormalities during sleep (a condition called sleep disordered breathing, the most common of which is obstructive sleep apnoea). As the breathing changes worsen in severity, it may result in a rise in carbon dioxide levels during daytime causing a condition called obesity hypoventilation syndrome (OHS). The current treatment for obesity related breathing changes include supportive breathing therapy at night, optimisation of associated medical conditions and weight loss. Weight management is an important part of obesity treatment. Weight loss strategies such as life-style modification do not always work. Weight loss surgery (bariatric surgery) has been shown to be an effective weight management intervention with long-term results. This study aims to understand breathing changes that occurs due to obesity and their resolution after weight loss surgery. The investigators are aiming to recruit participants with sleep disordered breathing who are currently awaiting bariatric surgery. In particular, the investigators are interested in comparing breathing changes in participants with OHS, who have abnormal regulation of their carbon dioxide levels, and participants with sleep disordered breathing with normal CO2 regulation. Participants will be recruited through outpatient clinics for sleep disordered breathing. The participants will undergo comprehensive breathing assessments on enrolment including an overnight sleep study. Participants will undergo further daytime breathing assessments before and after their bariatric surgery. End of study will be 6 months after surgery - participants will have a final comprehensive breathing assessment including an overnight sleep study to review resolution of their breathing changes. Depending on the wait list time for the bariatric surgery, it is anticipated that participants will be enrolled in the study for 2 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 2024
Est. primary completion date July 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: 1. Patients 18 years or older 2. BMI > 40 3. Patients with significant sleep disordered breathing requiring treatment 4. Patient is being assessed for bariatric surgery for either gastric sleeve or gastric bypass surgery Exclusion Criteria: 1. Patients with decompensated hypercapnic respiratory failure (pH< 7.3) 2. Chronic hypercapnic respiratory failure due to a cause other than obesity such as neuromuscular, chest wall or airway disease 3. Unstable cardiac disease including coronary artery disease and heart failure 4. Significant co-morbid psychiatric disease requiring anti-psychotic medications 5. Chronic pain syndrome on high dose opioid medications 6. Treatment for drug or alcohol addiction 7. Cognitive impairment that would prevent informed consent 8. Pregnancy 9. Need for long-term renal replacement therapy 10. Patients who undergo bariatric intervention with gastric balloon or gastric band.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Bariatric Surgery
Weight loss surgery with either gastric sleeve or gastric bypass surgery

Locations

Country Name City State
United Kingdom Guy's and St Thomas' NHS Trust London

Sponsors (1)

Lead Sponsor Collaborator
Guy's and St Thomas' NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Spectrum of sleep disordered breathing We will look at sub-group analyses for outcomes 1-29 based on degree of hypoventilation as defined by ERS/ESRS working group Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Other Choice of bariatric surgery We will investigate whether outcomes 1-29 is different depending on type of surgery the patient undergoes (gastric bypass compared to gastric sleeve) Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Primary Expiratory flow limitation as measured by forced oscillation testing Measurement of expiratory flow limitation at different position including upright, 45 degrees and supine. We will explore whether expiratory flow limitation can differentiate hypercapnic and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patients has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Primary Degree of change in expiratory flow limitation Explore whether the degree of positional change in expiratory flow limitation can differentiate between eucapnic and hypercapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Closing capacity Measurement of closing capacity at different position including upright, 45 degrees and supine. We will explore whether expiratory flow limitation can differentiate hypercapnic and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Degree of change in closing capacity Explore whether the degree of positional change in closing capacity can differentiate between eucapnic and hypercapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Correlation between closing capacity and expiratory flow limitation Compare outcome 1 and 3 to explore whether there is a relationship between expiratory flow limitation and closing capacity Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Intra-abdominal pressure We will measure intra-abdominal pressure and explore whether hypercapnic patients have increased intra-abdominal pressure. Positional changes will be measured Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Correlation between intra-abdominal pressure, closing capacity and expriatory flow limitation Compare outcome 1,3 and 6. This is a complex multi-compartment model that can differentiate hypercapnia and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Upper airway collapsibility Measurement of upper airway collapsibility as measure by negative expiratory pressure. Explore whether there is a relationship between hypercapnic and eucapnic patients depending on degree of upper airway collapsibility Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Lung compliance Measurement of lung compliance with pressure volume curve including measurements in different positions (upright, 45 degrees and supine) Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Respiratory muscle strength (maximal inspiratory pressure/maximal expiratory) Measurement of inspiratory and expiratory muscle strength Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Respiratory muscle strength (SNIP test) Measurement of sniff nasal inspiratory pressure Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Daytime neural respiratory drive (para-sternal electromyography measurements) Daytime neural respiratory drive as measured by parasternal electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Daytime neural respiratory drive (diaphragm electromyography measurements) Daytime neural respiratory drive as measured by diaphragm electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Nocturnal neural respiratory drive (para-sternal electromyography measurements) Nocturnal neural respiratory drive as measured by parasternal electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Nocturnal neural respiratory drive (diaphragm electromyography measurements) Nocturnal neural respiratory drive as measured by diaphragm electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Quality of life post bariatric surgery with SF-36 Quality of life changes after bariatric surgery more than with standard medical therapy Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Quality of life post bariatric surgery with EQ-5D Quality of life changes after bariatric surgery more than with standard medical therapy Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Symptom change after commencement of medical therapy compared to bariatric surgery measured with Epworth Sleepiness Scale Symptom change after bariatric surgery is more than with standard medical therapy Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Symptom change after commencement of medical therapy compared to bariatric surgery measured with mMRC (modified medical research council) dypnoea score Symptom change after bariatric surgery is more than with standard medical therapy Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Symptom change after commencement of medical therapy compared to bariatric surgery measured with Multi-dimensional dyspnoea profile Symptom change after bariatric surgery is more than with standard medical therapy Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Symptom change after commencement of medical therapy compared to bariatric surgery measured with Severe Respiratory Insufficiency Questionnaire Symptom change after bariatric surgery is more than with standard medical therapy Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Changes in healthcare resource usage in OHS patients post bariatric surgery Estimation of healthcare usage cost in the 6 months prior to surgery and 6 months post surgery including medication costs and re-admissions to hospital 6 months pre bariatric surgery and 6 months post bariatric surgery
Secondary Improvement in daytime CO2 levels Arterial blood gas performed before and after bariatric surgery with improvement in CO2 levels Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Improvement in apnoea-hyponoea index Patients will have diagnostic sleep study before and after bariatric surgery Before bariatric surgery on enrolment and 6 months after bariatric surgery
Secondary Improvement in mean nocturnal oxygen saturation during sleep Patients will have diagnostic sleep study before and after bariatric surgery Before bariatric surgery on enrolment and 6 months after bariatric surgery
Secondary Improvement in mean time spent below 90% oxygen saturation during sleep Patients will have diagnostic sleep study before and after bariatric surgery Before bariatric surgery on enrolment and 6 months after bariatric surgery
Secondary Changes in sleep architecture measured by %slow wave sleep and %REM sleep Patients will have diagnostic sleep study before and after bariatric surgery Before bariatric surgery on enrolment and 6 months after bariatric surgery
Secondary Improvement in diaphragm function Diaphragm thickening will be measured by ultrasound assessment Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
Secondary Improvement in glycaemic control HbA1C will be measured before and after bariatric surgery Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06367686 - Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor
Completed NCT06442163 - Average Volume-assured Pressure Support as Rescue Therapy in Obesity Hypoventilation Syndrome N/A
Not yet recruiting NCT05805293 - HVNI Versus NIV In Management Of Acute Hypercapnic Respiratory Failure In OHS N/A
Active, not recruiting NCT05167201 - Domiciliary Nasal High Flow and Patient Outcomes in Chronic Hypercapnic Respiratory Failure in the United Kingdom N/A
Completed NCT04884165 - Remote Monitoring to Improve Low Adherence in Non-invasive Ventilation N/A
Recruiting NCT06090149 - Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients N/A
Active, not recruiting NCT05448443 - Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome Phase 2
Recruiting NCT04688125 - Evaluation of An Optical Measurement Algorithm Combined With Patient and Provider Input to Reduce Mask Exchanges During Initial Positive Airway Pressure Therapy
Recruiting NCT05398068 - Effects of Exercise Training on Exercise Capacity and Sleep Quality in Patients With Obesity Hypoventilation Syndrome N/A
Withdrawn NCT04317326 - "Post-acute Pickwick Study" (Postacute-Pick-2020) N/A
Completed NCT04615078 - Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES Program) Compared to Standard of Care in Patients With Chronic Respiratory Failure Receiving Non-invasive Home Ventilation N/A
Completed NCT04835558 - Respiratory Muscle Endurance in Obesity Hypoventilation Syndrome
Completed NCT04570540 - Obesity in Sleep Medicine - Focusing on OHS Phenotypes
Not yet recruiting NCT06136533 - The Effect of Sarcopenic Obesity on Sleep in Individuals With Obesity Hypoventilation Syndrome
Withdrawn NCT01991535 - Response to NonInvasive Mechanical Ventilation According to the Breathing Pattern N/A